🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Tumor Burden

Cerebrovascular Disease: Quality of Life (CODE: QoL) NCT06443268n/a1 site📍 Zurich University of Zurich · Tests: questionnaire, hair samples, blood samples, clinical exam Compassion-Based Intervention for Lung Cancer Caregivers (CBI-LCC) NCT06930313NA1 site📍 Taipei Taipei Medical University · Tests: Brief Compassion-Based Intervention (BCI), Telephone-Based Support and Education (TSE) Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity NCT04273061Phase 22 sites📍 Vancouver📍 Toronto British Columbia Cancer Agency · Tests: Atezolizumab Singing Training vs Usual Care 6-18 Months After Surgical Resection for Non-small Cell Lung Cancer (NSCLC) NCT07460999NA5 sites📍 Copenhagen📍 Copenhagen📍 Næstved Zealand University Hospital · Tests: Singing training (Singing for Lung Health (SLH)), Control group: Usual care Assessment of Disease Burden in Hairy Cell Leukemia NCT06781515NA1 site📍 Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna · Tests: Peripheral and BM blood sample Regulating Emotions and Behaviors After Brain Injury NCT05393492NA1 site📍 Illkirch-Graffenstaden University Hospital, Strasbourg, France · Tests: Dialectical Behavior Therapy and Radically Open dialectical behavior therapy DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition NCT05770102Phase 2, Phase 327 sites📍 Belfast📍 Birmingham📍 Birmingham Cancer Research UK · Tests: Atezolizumab AXIS MG Patient Registry NCT07761026n/a1 site📍 Framingham Autoimmune Neurology Alliance A Study of Meaning-Centered Psychotherapy for Caregivers to People With Cancer NCT06307535NA8 sites📍 Miami📍 Basking Ridge📍 Middletown Icahn School of Medicine at Mount Sinai · Tests: Meaning-Centered Psychotherapy for Caregivers, Supportive Psychotherapy for Caregivers Prostate Cancer Burden and Heterogeneity Evaluation Towards Liquid Biopsy: a Correlation Study to 18FDCFPyL PET and Patients Outcome NCT06917781NA1 site📍 Toulouse Institut Claudius Regaud · Tests: Patients with 18F-PET-PSMA indication Plan Development for Giving Teclistamab in the Outpatient Setting NCT06251076Phase 41 site📍 Toronto University Health Network, Toronto · Tests: Teclistamab, Tocilizumab HematoCare: Feasibility of a Survivorship Care Plan for Hematologic Cancer Patients Undergoing HSCT NCT07579065NA1 site📍 Reggio Emilia Azienda USL Reggio Emilia - IRCCS · Tests: Survivorship Care (SC) Plan Adjuvant Trastuzumab Plus Neratinib in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer After Neoadjuvant Trastuzumab Plus Pertuzumab NCT05760612Phase 31 site📍 Guangzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Tests: Trastuzumab and neratinib, Trastuzumab and Pertuzumab Analysis of Multimodal Psychosomatic Comorbidity Burden in Breast Cancer and Benefit Evaluation of Acupuncture Collaborative Management Regimen NCT07763587NA3 sites📍 Tianjin📍 Tianjin📍 Tianjin First Teaching Hospital of Tianjin University of Traditiona… · Tests: Acupuncture A Community Health Education Intervention for Increasing Community-driven Actions to Reduce the Cancer Burden in Western New York NCT06681077NA1 site📍 Buffalo Roswell Park Cancer Institute · Tests: Community Health Education, Telephone Based Intervention Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma NCT06337318Phase 3288 sites📍 Birmingham📍 Phoenix📍 Tucson National Cancer Institute (NCI) · Tests: Biospecimen Collection, Computed Tomography, Mosunetuzumab, Positron Emission Tomography, Rituximab FARD (RaDiCo Cohort) (RaDiCo-FARD) NCT05954416n/a15 sites📍 Bobigny📍 Bordeaux📍 Bordeaux Institut National de la Santé Et de la Recherche Médicale, … The Effect of Education Brain Tumors NCT07617168NA1 site📍 Istanbul Istanbul University - Cerrahpasa · Tests: structured training based on the Life Model in Nursing HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer) NCT06930846NA1 site📍 Lebanon Dartmouth-Hitchcock Medical Center · Tests: HOBSCOTCH-CA Global Burden Estimation of Human Papillomavirus (GLOBE-HPV) NCT06129253n/a8 sites📍 Dhaka📍 Kinshasa📍 Ho International Vaccine Institute · Tests: Urine Sample Collection, Self-collected Vaginal Swab, Blood Samples The SNAP Tool for Head and Neck Cancer Survivor-Caregiver Dyads NCT05811936NA1 site📍 Charleston Medical University of South Carolina · Tests: Survivorship Needs Assessment Planning (SNAP) tool Ropeginterferon Alfa-2b in Patients With Polycythemia Vera (PV) Without Symptomatic Splenomegaly NCT06743035n/a1 site📍 Hanover iOMEDICO AG Targeting Osteosarcopaenia and Multimorbidity for Frailty Prevention NCT06073106n/a1 site📍 Singapore Tan Tock Seng Hospital Preparing for Life and Academics for Young Childhood Cancer Survivors NCT06769334NA1 site📍 Columbus Nationwide Children's Hospital · Tests: PLAY Program Reducing Symptom Burden Through Physical Exercise in Melanoma Patients NCT06985056NA1 site📍 Essen Universität Duisburg-Essen · Tests: Supervised 12-week Resistance and Endurance Exercise Program Omission of Axillary Surgery in Breast Cancer Patients NCT06259513NA1 site📍 Singapore KK Women's and Children's Hospital · Tests: omission of SLNB in SentiOMIT or omission of ALND in SentiMACRO 18F-MFBG PET/CT in the Evaluation of Neural Crest Tumor NCT05069220EARLY Phase 11 site📍 Beijing Peking Union Medical College Hospital · Tests: 18F-MFBG, 68Ga-Dotatate Investigating Utility of ctDNA and Tumour Evolution in Advanced Thyroid Cancer NCT05837260n/a1 site📍 London Royal Marsden NHS Foundation Trust · Tests: Sample collection only MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs) NCT07362225n/a2 sites📍 Chicago📍 New York MPN Research Foundation Emotion and Symptom-Focused Engagement (EASE) for Caregivers NCT06367556NA2 sites📍 Toronto📍 Toronto University Health Network, Toronto · Tests: Emotion and Symptom-Focused Engagement (EASE)
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy